From: Racial disparities in triple negative breast cancer: toward a causal architecture approach
 | TNBC (N = 453) | Non-TNBC (N = 2863) | Total (N = 3316) | p-values |
---|---|---|---|---|
Age at diagnosis, mean (SD)** | 60.2 (14.6) | 63.0 (13.2) | 62.6 (13.4) |  < 0.001 |
Race, n (%)** |  < 0.001 | |||
 White | 274 (60.5) | 2266 (79.1) | 2540 (76.6) | – |
 Black/African American | 179 (39.5) | 597 (20.9) | 776 (23.4) | – |
Insurance, n (%)* | Â | 0.015 | ||
 Private | 251 (55.4) | 1470 (51.3) | 1721 (51.9) | 0.468 |
 Medicare†| 162 (35.8) | 1207 (42.2) | 1369 (41.3) | 0.041 |
 Medicaid/none | 37 (8.2) | 156 (5.4) | 193 (5.8) | 0.120 |
 Unknown | 3 (0.7) | 30 (1.0) | 33 (1.0) | 1.000 |
Stage of diagnosisa, n (%)** |  < 0.001 | |||
 Early stage††| 381 (84.1) | 2637 (92.1) | 3018 (91.0) |  < 0.001 |
 Late stage††| 67 (14.8) | 205 (7.2) | 272 (8.2) |  < 0.001 |
 Unknown stage | 5 (1.1) | 21 (0.7) | 26 (0.8) | 1.000 |
Census tract ICE-Race, n (%)** |  < 0.001 | |||
 Q1††(most disadvantaged) | 104 (23.0) | 367 (12.8) | 471 (14.2) |  < 0.001 |
 Q2 | 102 (22.5) | 585 (20.4) | 687 (20.7) | 1.000 |
 Q3 | 103 (22.7) | 694 (24.2) | 797 (24.0) | 1.000 |
 Q4 | 95 (21.0) | 621 (21.7) | 716 (21.6) | 1.000 |
 Q5††(most advantaged) | 49 (10.8) | 596 (20.8) | 645 (19.5) |  < 0.001 |
Census tract ICE-Income, n (%)** |  < 0.001 | |||
 Q1††(most disadvantaged) | 80 (17.7) | 359 (12.5) | 439 (13.2) | 0.028 |
 Q2 | 96 (21.2) | 487 (17.0) | 583 (17.6) | 0.298 |
 Q3 | 64 (14.1) | 475 (16.6) | 539 (16.3) | 1.000 |
 Q4 | 114 (25.2) | 699 (24.4) | 813 (24.5) | 1.000 |
 Q5††(most advantaged) | 99 (21.9) | 843 (29.4) | 942 (28.4) | 0.009 |
Census tract ICE-Race/Income, n (%)** |  < 0.001 | |||
 Q1††(most disadvantaged) | 82 (18.1) | 329 (11.5) | 411 (12.4) | 0.001 |
 Q2 | 112 (24.7) | 547 (19.1) | 659 (19.9) | 0.054 |
 Q3 | 77 (17.0) | 562 (19.6) | 639 (19.3) | 1.000 |
 Q4 | 94 (20.8) | 693 (24.2) | 787 (23.7) | 1.000 |
 Q5††(most advantaged) | 88 (19.4) | 732 (25.6) | 820 (24.7) | 0.049 |